tradingkey.logo
tradingkey.logo
Buscar

Biomerica Inc

BMRA
Añadir a la lista de seguimiento
1.750USD
-0.020-1.13%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
5.16MCap. mercado
PérdidaP/E TTM

Más Datos de Biomerica Inc Compañía

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Información de Biomerica Inc

Símbolo de cotizaciónBMRA
Nombre de la empresaBiomerica Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoIrani (Zackary S)
Número de empleados53
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección17571 Von Karman Avenue
CiudadIRVINE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92614
Teléfono19493792875
Sitio Webhttps://biomerica.com/
Símbolo de cotizaciónBMRA
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoIrani (Zackary S)

Ejecutivos de Biomerica Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Biomerica Inc?

Los cinco principales accionistas de Biomerica Inc son: Mr. Zackary S. Irani

¿Cuántas instituciones poseen acciones de Biomerica Inc (BMRA)?

A fecha de 2026Q1, 59 instituciones poseen acciones de Biomerica Inc, con un valor de mercado combinado de aproximadamente 94.38K, lo que representa el 3.05% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -250592.00.

¿Cuál es la mayor fuente de ganancias de Biomerica Inc?

El 2026Q1, el segmento empresarial Clinical Lab generó la ganancia más alta para Biomerica Inc, ascendiendo a 676.00K y representando el 55.87% de la ganancia total.